ActiGraph Announces Acquisition by ArchiMed


Applied Clinical Trials

ActiGraph has announced that it has been acquired ArchiMed. Their investment in ActiGraph’s employees, technology, and capabilities will allow the company to expand its patient monitoring solutions portfolio to support the development of therapies. The company’s digital remote monitoring platform is particularly well-suited for site less/virtual trials, which have become fundamental to sustaining clinical research and protecting patients amid the COVID-19 pandemic.

For more information, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.